Frazier Life Sciences Management’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $120M | Buy |
|
|||||
|
2025
Q1 | $63.4M | Hold |
|
|||||
|
2024
Q4 | $82.1M | Hold |
|
|||||
|
2024
Q3 | $183M | Hold |
|
|||||
|
2024
Q2 | $104M | Hold |
|
|||||
|
2024
Q1 | $107M | Hold |
|
|||||
|
2023
Q4 | $92.3M | Hold |
|
|||||
|
2023
Q3 | $105M | Hold |
|
|||||
|
2023
Q2 | $145M | Buy |
|
|||||
|
2023
Q1 | $60M | Hold |
|
|||||
|
2022
Q4 | $94.3M | Hold |
|
|||||
|
2022
Q3 | $93.2M | Buy |
|
|||||
|
2022
Q2 | $49.2M | Hold |
|
|||||
|
2022
Q1 | $79.3M | Buy |
|